Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
tc2000chartreader's Profile
Displaying 1-50 of 2878 result(s).
GNBTQ Generex Biotechnology Corp.
03/05/2021 12:30:11 PM
Was watching MSNBC this morning and (4)
GNBTQ Generex Biotechnology Corp.
03/05/2021 12:27:35 PM
Looking at those transactions, ever (2)
GNBTQ Generex Biotechnology Corp.
03/04/2021 3:29:47 PM
doc, that was a little TOO graphic. (1)
GNBTQ Generex Biotechnology Corp.
03/04/2021 12:52:34 PM
Full Disclosure, I bought just a fe (4)
GNBTQ Generex Biotechnology Corp.
03/04/2021 12:10:33 PM
Very true, 3 S1s were filed with FI (6)
GNBTQ Generex Biotechnology Corp.
03/04/2021 11:42:08 AM
You are right buildit, NGIO IPO is (9)
GNBTQ Generex Biotechnology Corp.
01/10/2021 6:31:51 PM
True doc, but we haven’t been tol
GNBTQ Generex Biotechnology Corp.
01/10/2021 5:38:33 PM
https://www.investopedia.com/ask/a (1)
GNBTQ Generex Biotechnology Corp.
01/10/2021 5:35:48 PM
Forgot all about the preferred shar
GNBTQ Generex Biotechnology Corp.
01/10/2021 5:34:12 PM
You are comparing an unknown NGIO v
GNBTQ Generex Biotechnology Corp.
01/10/2021 4:19:31 PM
Actually I can’t imagine the mark (1)
GNBTQ Generex Biotechnology Corp.
01/10/2021 1:37:37 PM
I guess after NGIO gets listed. GNB (2)
GNBTQ Generex Biotechnology Corp.
01/09/2021 6:37:29 PM
About 9.1% of the 400.300,000 so 36 (1)
GNBTQ Generex Biotechnology Corp.
01/09/2021 10:29:33 AM
I don’t agree with this. I think (6)
GNBTQ Generex Biotechnology Corp.
01/09/2021 10:16:12 AM
Wow, never considered a reverse spl (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 5:22:58 PM
This sounds positive... “ This th (4)
GNBTQ Generex Biotechnology Corp.
01/08/2021 5:21:35 PM
2/5 conf call at 9AM, sorry rjs htt (1)
GNBTQ Generex Biotechnology Corp.
01/08/2021 5:19:33 PM
If we can sell...lol. Seriously, we (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 3:55:59 PM
Well remember, any company is only (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 3:51:01 PM
I always thought 400M shares was wa (2)
GNBTQ Generex Biotechnology Corp.
01/08/2021 3:14:04 PM
This is a disappointing valuation. (2)
GNBTQ Generex Biotechnology Corp.
01/07/2021 2:00:41 PM
I don't have a direct line to ask J (2)
GNBTQ Generex Biotechnology Corp.
01/07/2021 1:19:44 PM
hylander, your logic is wrong...lol
GNBTQ Generex Biotechnology Corp.
01/07/2021 1:16:32 PM
Not saying that is how it should be (1)
GNBTQ Generex Biotechnology Corp.
01/07/2021 12:47:10 PM
I believe rjs tried to answer this (1)
GNBTQ Generex Biotechnology Corp.
01/07/2021 12:43:27 PM
Buildit, that is a very good point. (2)
GNBTQ Generex Biotechnology Corp.
01/07/2021 12:21:53 PM
Don't think we will see an 8K. They (1)
GNBTQ Generex Biotechnology Corp.
01/07/2021 11:58:17 AM
OT... specifically one in a 'costum (5)
GNBTQ Generex Biotechnology Corp.
01/06/2021 2:03:10 PM
I think you are reaching for straws (2)
GNBTQ Generex Biotechnology Corp.
01/06/2021 1:23:50 PM
While that would be a great idea, s
GNBTQ Generex Biotechnology Corp.
01/05/2021 9:29:34 PM
So that brings up the point, that s (4)
GNBTQ Generex Biotechnology Corp.
01/05/2021 8:29:29 PM
My suggestion was why did they give (2)
GNBTQ Generex Biotechnology Corp.
01/05/2021 3:39:20 PM
It’s more interesting that GNBT r (2)
GNBTQ Generex Biotechnology Corp.
01/04/2021 6:35:48 PM
Exactly. Incentives are there to en (1)
GNBTQ Generex Biotechnology Corp.
01/04/2021 4:08:18 PM
I agree Cody. However human tendenc (2)
GNBTQ Generex Biotechnology Corp.
01/04/2021 3:16:47 PM
Well, for 1 thing, they are on the (3)
GNBTQ Generex Biotechnology Corp.
01/04/2021 2:18:31 PM
Bonus shares are usually locked up (1)
GNBTQ Generex Biotechnology Corp.
01/04/2021 2:11:10 PM
Would be interesting to know where (5)
GNBTQ Generex Biotechnology Corp.
01/04/2021 2:06:35 PM
Let's hope the share bonus will be (2)
GNBTQ Generex Biotechnology Corp.
12/29/2020 6:49:48 PM
Just checked my 12/2019 statement a (2)
GNBTQ Generex Biotechnology Corp.
12/29/2020 6:38:25 PM
You are probably right. Most system (1)
GNBTQ Generex Biotechnology Corp.
12/29/2020 4:13:25 PM
12/31/2019 closing price $0.4429. N
GNBTQ Generex Biotechnology Corp.
12/29/2020 4:01:54 PM
exactly doc. 9%/day would double yo (1)
GNBTQ Generex Biotechnology Corp.
12/29/2020 3:54:13 PM
Over 1M shares trading today at the (2)
GNBTQ Generex Biotechnology Corp.
12/28/2020 12:53:22 PM
Huge increase in warrants, which cu
GNBTQ Generex Biotechnology Corp.
12/17/2020 9:01:43 PM
Well tomato tomato, you know what I
GNBTQ Generex Biotechnology Corp.
12/17/2020 8:20:37 PM
Does it? On November 13, 2020, Gene
GNBTQ Generex Biotechnology Corp.
12/17/2020 4:18:26 PM
Well, now we know the answer to my (4)
GNBTQ Generex Biotechnology Corp.
12/16/2020 6:14:47 PM
Yea but it also says they want a jo (1)
GNBTQ Generex Biotechnology Corp.
12/16/2020 4:09:55 PM
Yes, AE was wholly owned, not anymo (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Mitto Scores Prestigious Spot in 2025 CPaaS Magic Quadrant
  • Join Global Innovators at the FHC Shanghai Beverage Expo
  • LONGi Hi-MO 9 Ice-Shield Modules: Pioneering Solar Safety
  • Key Insights for Investors as Fed Decisions Loom Ahead
  • Industrial Stocks Surge as Big Tech Loses Its Dominance
  • Powell's Press Conference: All Eyes on Future Rate Decisions
  • HTX Introduces Innovative Crypto Gifts and Exciting Prizes
  • Enhancing AI with Aurora Mobile and Zhipu AI Integration
  • Madrigal Pharmaceuticals Strikes Global License for SYH2086
  • Check Point Software Achieves Impressive Q2 2025 Growth
  • Key Transactions by Corporate Leaders at Danske Bank Revealed
  • Call for Action Against Starlink Utilization by Scammers
  • Zuckerberg's AI Ambitions: Targeting Top Talent Amidst Controversy
  • New Oriental's Fiscal Year 2025 Financial Performance Review
  • Check Point Software Reveals Strong Q2 2025 Financial Results
  • New Oriental's Strong Q4 Results Reflect Growth and Strategy
  • Innovative Partnership Enhances Access to Oncology Insights Globally
  • Global Seed Treatment Market Analysis and Future Trends
  • Navigating Summer Spending: Tips to Stay Financially Smart
  • Unleashing Adventure: Jurassic World Experience with Prezzee
  • Innovative Business Growth Solutions for 2025: QuickBooks
  • Opendoor's Stock Volatility in Focus: What Investors Should Know
  • RD Technologies Raises $40 Million to Propel Fintech Innovations
  • TECO Electric and Foxconn Forge Alliance for AI Data Centers
  • Exploring New Frontiers at FHC Shanghai Global Food Show
  • Scott Bessent Highlights Trump's Role in US-China Trade Talks
  • Starbucks Thrives Under Leadership of Brian Niccol Amid Changes
  • Exploring the Growing Market for Lenacapavir Injections
  • Overview of BofA Securities Europe SA Shareholding Changes
  • Understanding Public Disclosure by Apax Global Alpha Limited
  • Festi hf. Reports Strong Performance in Q2 2025 Financial Results
  • Understanding Exempt Principal Trader Dealings in NCC Group
  • Recent Trading Disclosures by Dowlais Group Plc and Investec Bank
  • Festi hf. Unveils Second Quarter 2025 Financial Highlights
  • Foxconn and TECO Forge Alliance to Transform AI Data Centers
  • Revolutionizing Industries: The Rise of Intelligent Robots
  • Foxconn and TECO Forge Strategic Alliance for AI Data Centers
  • HBX Group Reports Strong Q3 Results, Growth Strategy in Place
  • Strategic Alliance to Advance Innovative Therapies for IBD
  • Unlocking the Future of Real-Time Clock ICs in Tech Growth
  • FG Nexus Inc. Moves Forward with $200M Placement Strategy
  • Rakovina and UBC Foster Innovation in Cancer Treatment
  • Atos Achieves Fifth Time Recognition as CDP Supplier Leader
  • Key Developments in the Strategic Review of Octopus Titan VCT
  • Recent Share Buy-Back Activities by ROCKWOOL A/S Explained
  • Understanding Nissan's Financial Impact on Renault's Earnings
  • Insights on Octopus Titan VCT's Upcoming Strategic Plans
  • Bank Leumi's Financial Results Preview: Key Insights Ahead
  • The Future of Electric Vehicle Tires: Trends and Innovations
  • FundedFX Revolutionizes Trading with Innovative Challenges
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site